You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALT-803

Showing 1 - 25 of 489
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

Completed
  • FIGO Stage III and IV Ovarian Cancer
  • +2 more
  • ALT-803 Subcutaneous
  • ALT-803 Intraperitoneal
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Oct 5, 2022

NSCLC Trial in United States (ALT-803, Nivolumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • ALT-803
  • Nivolumab
  • Weston, Florida
  • +3 more
Dec 5, 2022

Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Sep 25, 2023

Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)

Not yet recruiting
  • Lynch Syndrome
  • Biopsy
  • +5 more
  • Phoenix, Arizona
  • +13 more
Sep 16, 2022

Bladder Cancer Trial in United States (N-803 and BCG, N-803)

Recruiting
  • Bladder Cancer
  • Anchorage, Alaska
  • +31 more
Oct 26, 2022

Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

Recruiting
  • Acute Myeloid Leukemia
  • Graft cell infusion
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

HIV/AIDS Trial in Bangkok (N-803)

Recruiting
  • HIV/AIDS
  • Bangkok, Thailand
    Thai Red Cross AIDS Research Centre
Oct 4, 2021

QUILT-3.032 and of QUILT-2.005

Terminated
  • Pharmacokinetics
  • BCG in Combination with N-803
  • N-803 alone
  • Los Angeles, California
  • +5 more
Jan 20, 2021

Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma Trial in United States (Rituximab, ALT-803)

Terminated
  • Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma
  • Rituximab
  • ALT-803
  • Minneapolis, Minnesota
  • +3 more
Feb 11, 2021

Acute Myeloid Leukemia Trial in Minneapolis (ALT-803)

Completed
Has Results
  • Acute Myeloid Leukemia
  • ALT-803
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Oct 30, 2020

Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)

Withdrawn
  • Triple Negative Breast Cancer (TNBC)
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • mCRC
  • Aldoxorubicin Hydrochloride
  • +19 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Merkel Cell Carcinoma Trial in United States (Avelumab, N-803, haNK™)

Terminated
  • Merkel Cell Carcinoma
  • Avelumab
  • +2 more
  • San Francisco, California
  • +4 more
Jan 7, 2022

Non Small Cell Lung Cancer Trial in El Segundo (Nab-paclitaxel, Cisplatin, 5Fluorouracil)

Withdrawn
  • Non Small Cell Lung Cancer
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Hiv, HIV, Immune Deficiency Trial in Minneapolis (Haploidentical Natural Killer (NK) Cells)

Completed
  • Hiv
  • +2 more
  • Haploidentical Natural Killer (NK) Cells
  • Minneapolis, Minnesota
    University of Minnesota
Apr 21, 2021

Non Hodgkin Lymphoma Trial (biological, drug, radiation)

Withdrawn
  • Non Hodgkin Lymphoma
  • avelumab
  • +13 more
  • (no location specified)
Mar 17, 2021

Colorectal Cancer Trial (biological, drug, radiation)

Withdrawn
  • Colorectal Cancer
  • avelumab
  • +21 more
  • (no location specified)
Mar 17, 2021

Chordoma, Unresectable Malignant Tumor Trial in El Segundo (biological, drug, radiation)

Withdrawn
  • Chordoma
  • Unresectable Malignant Neoplasm
  • Aldoxorubicin Hydrochloride
  • +9 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 17, 2021

Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Berkeley

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +8 more
  • Cobalamin
  • +8 more
  • Birmingham, Alabama
  • +349 more
Oct 18, 2022

Merkel Cell Carcinoma Trial (biological, drug, radiation)

Withdrawn
  • Merkel Cell Carcinoma
  • Avelumab
  • +14 more
  • (no location specified)
Mar 17, 2021

Metastatic Pancreatic Cancer Trial in El Segundo (Gemcitabine, Nab-paclitaxel, Aldoxorubicin HCl)

Withdrawn
  • Metastatic Pancreatic Cancer
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 17, 2021

Triple Negative Breast Cancer Trial (biological, drug, radiation)

Withdrawn
  • Triple Negative Breast Cancer
  • avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Melanoma Trial (biological, drug, radiation)

Withdrawn
  • Melanoma
  • Avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Ovarian Cancer Trial (biological, drug, radiation)

Withdrawn
  • Ovarian Cancer
  • Avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Urothelial Carcinoma Trial (biological, drug, radiation)

Withdrawn
  • Urothelial Carcinoma
  • avelumab
  • +19 more
  • (no location specified)
Mar 17, 2021